ArticleVeterinary world2025
High seroprevalence, clinical predictors, and epidemiological risk factors of
Article in Veterinary world, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aim: Canine monocytic ehrlichiosis, caused by Materials and Methods: A cross-sectional analytical study was conducted from December 2023 to August 2024 involving 462 dogs with compatible clinical signs and/or tick infestation from 18 veterinary clinics across three districts. Serological testing was performed with the CaniV-4® rapid test, and hematological parameters were analyzed with an automated analyzer. Epidemiological data were obtained through owner questionnaires. Associations were evaluated using chi-square tests, logistic regression (Odds ratio [OR], 95% CI), and Mann-Whitney U tests for hematological differences. A p-value < 0.05 with OR and lower CI >1 defined risk factors. Results: The overall seroprevalence of Conclusion: The high seroprevalence and significant clinical-hematological alterations highlight widespread exposure to
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.